41 results on '"Jelicic, Jelena"'
Search Results
2. Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic review
3. Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models
4. Clinical Characteristics and Management of Patients With Concomitant Liver Cirrhosis and Lymphoma: A Systematic Review
5. A Real‐World Data‐Based Analysis of Prognostic Indices as Part of Trial Eligibility Criteria in Diffuse Large B‐Cell Lymphoma Patients.
6. Urban planning method for fostering social sustainability: Can bottom-up and top-down meet?
7. The clinical applicability of current prognostic models in follicular lymphoma: A systematic review
8. Prognostic models in primary central nervous system lymphoma patients: A systematic review
9. Revisiting beta‐2 microglobulin as a prognostic marker in diffuse large B‐cell lymphoma.
10. Real‐world outcomes following third or subsequent lines of therapy: A Danish population‐based study on 189 patients with relapsed/refractory large B‐cell lymphomas
11. Available prognostic models for risk stratification of diffuse large B cell lymphoma patients: a systematic review
12. Real‐world outcomes following third or subsequent lines of therapy: A Danish population‐based study on 189 patients with relapsed/refractory large B‐cell lymphomas.
13. Venous thromboembolic events in lymphoma patients: Actual relationships between epidemiology, mechanisms, clinical profile and treatment
14. Prognostic Significance of Cereblon Expression in Patients With Multiple Myeloma
15. Is it possible to improve prognostic value of NCCN-IPI in patients with diffuse large B cell lymphoma? The prognostic significance of comorbidities
16. Prognostic Effect of Comorbidity Indices in Elderly Patients With Multiple Myeloma
17. Is It Possible to Omit Bone Marrow Biopsy in Diagnostic Workup in Patients with Newly Diagnosed Primary CNS Lymphoma? a Retrospective Analysis in the PET/CT Era
18. Outcome after 3rd Line Treatment for Diffuse Large B-Cell Lymphoma: A Danish Population-Based Study
19. Is It Possible to Omit Bone Marrow Biopsy in Diagnostic Workup in Patients with Newly Diagnosed Primary CNS Lymphoma? a Retrospective Analysis in the PET/CT Era
20. FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma
21. The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients
22. The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas
23. Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort study
24. Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphoma
25. P-161: Ultra-high-risk prognostic significance of double and triple hit myeloma
26. Single-Center Experience in the Treatment of Primary Testicular Lymphoma
27. Statistical Challenges in Development of Prognostic Models in Diffuse Large B-Cell Lymphoma: Comparison Between Existing Models – A Systematic Review
28. Influence of applied CD34+ cell dose on the survival of Hodgkin's lymphoma and multiple myeloma patients following autologous stem cell transplants
29. Clinicopathological and fluorescence in situ hibridisation analysis of primary testicular diffuse large B-cell lymphoma: a single-centre case series
30. Concomitant chronic lymphocytic leukemia and Merkel cell carcinoma
31. The role of high-dose therapy and autologous stem cell transplantation in the treatment of patients with multiple myeloma
32. A Population-Based Study on Performance of Clinical Prognostic Models in Patients with Diffuse Large B-Cell Lymphoma Younger Than 70 Years
33. Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients
34. Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses
35. Is it possible to improve prognostic value of NCCN-IPI in patients with diffuse large B cell lymphoma? The prognostic significance of comorbidities.
36. The possible benefit from total tumour resection in primary diffuse large B-cell lymphoma of central nervous system – a one-decade single-centre experience
37. Outcome after 3rdLine Treatment for Diffuse Large B-Cell Lymphoma: A Danish Population-Based Study
38. An approach to optimal architectural and urban design from the energy efficiency point of view
39. Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses.
40. The possible benefit from total tumour resection in primary diffuse large B-cell lymphoma of central nervous system – a one-decade single-centre experience.
41. BCL2 positive and BCL6 negative diffuse large B cell lymphoma patients benefit from R-CHOP therapy irrespective of germinal and non germinal center B cell like subtypes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.